(Total Views: 502)
Posted On: 03/14/2019 8:07:26 PM
Post# of 15624
this part is great also,....
“despite being young, the company is leading groundbreaking studies in the field of cannabis treatment for medical purposes, while keeping considerations of patient benefit and welfare at the forefront of its activity. Moreover, the company intends to expand its product portfolio while forming research and business collaborations with large companies in the pharma industry, and to launch its products in both the medical cannabis track and the FDA track.”
i get the sense this step has already been leaned into...and some positives have arisen. jmho.
“despite being young, the company is leading groundbreaking studies in the field of cannabis treatment for medical purposes, while keeping considerations of patient benefit and welfare at the forefront of its activity. Moreover, the company intends to expand its product portfolio while forming research and business collaborations with large companies in the pharma industry, and to launch its products in both the medical cannabis track and the FDA track.”
i get the sense this step has already been leaned into...and some positives have arisen. jmho.
(0)
(0)
